E76.21
Non-billableMorquio mucopolysaccharidoses
E76.21 is the ICD-10-CM code for Morquio mucopolysaccharidoses. It is a non-billable category code — use a more specific child code such as E76.210 for billing.
E00-E89 Endocrine, nutritional and metabolic diseases
What this means — in plain language
MedlinePlus · NIHMucopolysaccharidosis type IV (MPS IV), also known as Morquio syndrome, is a progressive condition that mainly affects the skeleton. The rate at which symptoms worsen varies among affected individuals. The first signs and symptoms of MPS IV usually become apparent during early childhood. Affected individuals develop various skeletal abnormalities, including short stature, knock knees, and abnormalities of the ribs,…
Read more about Mucopolysaccharidosis type IV at MedlinePlus ↗Source: U.S. National Library of Medicine (MedlinePlus). Informational only — not medical advice.
Medications indicated for this condition
FDA labeling- Elosulfase AlfaHydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]›
- GalsulfaseHydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]›
- IdursulfaseHydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]›
- LaronidaseHydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]›
- Tividenofusp Alfa›
- Vestronidase AlfaLysosomal beta Glucuronidase [EPC]›
Drugs whose FDA labeling lists this condition's category among its indications. Informational only — not a treatment recommendation or medical advice.
Frequently asked questions
Source: CMS ICD-10-CM FY2026. For informational purposes only — not medical advice. See our medical disclaimer.
Look up another ICD-10 code or condition